Fig. 2

A SRLncRNAs signature of prognosis in ccRCC patients. (A) SRlncRNAs coefficient distribution plot. (B) Partial likelihood deviation plot. (C-D) The training and testing sets’ risk groups, population distribution and SRlncRNAs’ expression. (E and G) In both the training and testing sets, Kaplan-Meier curves demonstrated that patients’ survival probabilities were lower in high than low risk groups. (F and H) ROC curves both showed the SRlncRNAs signature was highly sensitive and specific to predict ccRCC patients’ survival probability both in training and testing sets